Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.
Sec. Skin Cancer
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1484716

Sex-specific Difference for Melanoma from Immunotherapy Advancement

Provisionally accepted
Xu Liu Xu Liu 1*Qianqian Li Qianqian Li 1,2Ying Dong Ying Dong 2Yujiao Ma Yujiao Ma 2You Mo You Mo 1Jupeng Yuan Jupeng Yuan 1
  • 1 Shandong First Medical University, Tai'an, China
  • 2 Department of Radiation Oncology, Shandong Cancer Hospital, Jinan, Shandong Province, China

The final, formatted version of the article will be published soon.

    The evaluation of melanoma incidence and mortality trends based on population characteristics, with a particular focus on sex differences, is of utmost importance. Methods: The gender-stratified analysis of melanoma mortality across various calendar years was conducted. Utilizing the Joinpoint software, we detected alterations in the incidence rates and delineated the mortality trends. Results: Melanoma's incidence-based mortality exhibited a rising trajectory between 2005 and 2010, characterized by an annual percent change (APC) of 2.95%. However, there was a significant decrease in mortality from 2015 to 2019, with an APC of -4.39%. Notably, the mortality among men decreased by about 5.84% between 2015 and 2019, while there was no significant downward trend in the mortality rate among women. Subsequent analysis revealed no statistically significant variation in the 2-year survival rate of female patients aged 45-54 years among different age groups (Z=-0.775, p >0.1). Conclusions: Between 2015 and 2019, against the backdrop of stable melanoma incidence rates in the United States, there was a significant decline in mortality. Our analysis suggests that the utilization of immunotherapy may account for the observed reduction in mortality, with particularly notable benefits for male patients. However, female patients, especially younger women, did not derive significant advantages.

    Keywords: Melanoma, Sex, Incidence, Mortality, Immunotherapy

    Received: 22 Aug 2024; Accepted: 28 Oct 2024.

    Copyright: © 2024 Liu, Li, Dong, Ma, Mo and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Xu Liu, Shandong First Medical University, Tai'an, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.